Vis enkel innførsel

Effects of liraglutide vs. lifestyle changes on soluble suppression of tumorigenesis-2 (sST2) and galectin-3 in obese subjects with prediabetes or type 2 diabetes after comparable weight loss

dc.contributor.authorSimeone, Paola
dc.contributor.authorTripaldi, Romina
dc.contributor.authorMichelsen, Annika Elisabet
dc.contributor.authorUeland, Thor
dc.contributor.authorLiani, Rossella
dc.contributor.authorCiotti, Sonia
dc.contributor.authorBirkeland, Kåre I.
dc.contributor.authorGulseth, Hanne Løvdal
dc.contributor.authorDi Castelnuovo, Augusto
dc.contributor.authorCipollone, Francesco
dc.contributor.authorAukrust, Pål
dc.contributor.authorConsoli, Agostino
dc.contributor.authorHalvorsen, Bente
dc.contributor.authorSantilli, Francesca
dc.date.accessioned2022-05-11T07:42:47Z
dc.date.available2022-05-11T07:42:47Z
dc.date.created2022-05-10T14:32:22Z
dc.date.issued2022
dc.identifier.citationCardiovascular Diabetology. 2022, 21 (1), 1-12.
dc.identifier.issn1475-2840
dc.identifier.urihttps://hdl.handle.net/11250/2995176
dc.language.isoeng
dc.titleEffects of liraglutide vs. lifestyle changes on soluble suppression of tumorigenesis-2 (sST2) and galectin-3 in obese subjects with prediabetes or type 2 diabetes after comparable weight loss
dc.title.alternativeEffects of liraglutide vs. lifestyle changes on soluble suppression of tumorigenesis-2 (sST2) and galectin-3 in obese subjects with prediabetes or type 2 diabetes after comparable weight loss
dc.typePeer reviewed
dc.typeJournal article
dc.description.versionpublishedVersion
dc.source.pagenumber1-12
dc.source.volume21
dc.source.journalCardiovascular Diabetology
dc.source.issue1
dc.identifier.doi10.1186/s12933-022-01469-w
dc.identifier.cristin2023165
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail
Filnavn:
Simeone_2022_Eff.pdf
Størrelse:
1.078Mb
Format:
PDF
Åpne

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel